OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome
Joseph H. Butterfield
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2542-2546
Closed Access | Times Cited: 20

Showing 20 citing articles:

A US-Based Multicenter Retrospective Report of Perioperative Anaphylaxis, 2010-2021
Alexei Gonzalez‐Estrada, Ismael Carrillo‐Martin, Dan Morgenstern‐Kaplan, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 6, pp. 1594-1602.e9
Closed Access | Times Cited: 7

Using the Right Criteria for MCAS
Theo Gülen
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 2, pp. 39-51
Open Access | Times Cited: 6

Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in Mastocytosis
Matthew P. Giannetti, Jennifer Nicoloro‐SantaBarbara, Grace Godwin, et al.
Diagnostics (2024) Vol. 14, Iss. 2, pp. 123-123
Open Access | Times Cited: 5

A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis
Theo Gülen
Diagnostics (2023) Vol. 13, Iss. 21, pp. 3307-3307
Open Access | Times Cited: 10

Disease Spectrum of Anaphylaxis Disorders
David González‐de‐Olano, W. Cain, Jonathan A. Bernstein, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 7, pp. 1989-1996
Closed Access | Times Cited: 9

Urine Mast Cell Mediators in the Evaluation and Diagnosis of Mast Cell Activation Syndrome
Dayne Voelker, Thanai Pongdee
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 2, pp. 33-38
Closed Access | Times Cited: 3

Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?
Peter Valent, Cem Akin, Michel Arock
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 3, pp. 133-141
Open Access | Times Cited: 3

Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management
Matthew J. Hamilton
Current Gastroenterology Reports (2024) Vol. 26, Iss. 4, pp. 107-114
Closed Access | Times Cited: 3

Detecting Changes in Mast Cell Numbers Versus Activation in Human Disease: A Roadblock for Current Biomarkers?
Cem Akin, Frank Siebenhaar, Joshua B. Wechsler, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 7, pp. 1727-1737
Open Access | Times Cited: 3

Mast Cell–Targeting Therapies in Mast Cell Activation Syndromes
Vito Sabato, Michiel Beyens, Alessandro Toscano, et al.
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 2, pp. 63-71
Closed Access | Times Cited: 2

Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders
Taleb Zaghmout, Laura Maclachlan, Nawfal Bedi, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 12, Iss. 3, pp. 753-761
Open Access | Times Cited: 5

Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders
Michiel Beyens, Alessandro Toscano, Didier G. Ebo, et al.
Diagnostics (2023) Vol. 13, Iss. 24, pp. 3662-3662
Open Access | Times Cited: 5

Mast cell activation identified through urine mediators
Matthew P. Giannetti, Grace Godwin, Julia Middlesworth, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2531-2533
Closed Access | Times Cited: 1

Appraisal of the evidence linking hereditary α-tryptasemia with mast cell disorders, hypermobility and dysautonomia
Jonathan J. Lyons
Allergy and Asthma Proceedings (2024) Vol. 46, Iss. 1, pp. 4-10
Closed Access | Times Cited: 1

Role of Mast Cells in Eosinophilic Gastrointestinal Diseases
Paneez Khoury, Joshua B. Wechsler
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 2, pp. 311-327
Closed Access

Dilemma of Mast Cell Activation Syndrome: Overdiagnosed or Underdiagnosed?
Cem Akin
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 3, pp. 762-763
Open Access

Biomarkers in the diagnosis of mast cell activation
Dayne Voelker, Thanai Pongdee
Current Opinion in Allergy and Clinical Immunology (2024)
Open Access

Acute/baseline ratios of all 3 MC mediator metabolites can enhance diagnosis and management of mast cell activation syndrome.
Joseph H. Butterfield, Andrew W. Taylor
Journal of Allergy and Clinical Immunology Global (2024) Vol. 4, Iss. 2, pp. 100399-100399
Open Access

Systemic mastocytosis presenting with episodic rigors
Alyssa Kerber, Elizabeth A. Coon, Kaaren K. Reichard, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2955-2956
Closed Access

Page 1

Scroll to top